Intellectual Property Cases filed in New Jersey
Cases 21 - 30 of 90
EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 3:2021cv20723
Plaintiff: EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant: AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271
MEDICURE INTERNATIONAL, INC. v. AUROBINDO PHARMA LIMITED et al
as 2:2021cv17534
Counter Defendant: MEDICURE INTERNATIONAL, INC.
Counter Claimant: AUROBINDO PHARMA LIMITED and AUROBINDO PHARMA USA INC.
Defendant: EUGIA PHARMA SPECIALITIES LIMITED and AUROMEDICS PHARMA LLC
Cause Of Action: 35 U.S.C. § 271
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AUROBINDO PHARMA LTD. et al
as 3:2021cv13240
Plaintiff: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. and AUSPEX PHARMACEUTICALS, INC.
Defendant: AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. AUROBINDO PHARMA LIMITED et al
as 2:2021cv00624
Defendant: AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LIMITED, AUROLIFE PHARMA LLC and others
Plaintiff: CELGENE CORPORATION
Cause Of Action: 35 U.S.C. § 271
MERZ PHARMACEUTICALS, LLC et al v. AUROBINDO PHARMA USA INC. et al
as 3:2020cv20346
Plaintiff: MERZ PHARMACEUTICALS, LLC and MERZ NORTH AMERICA, INC.
Defendant: AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA INC.
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al
as 3:2020cv18334
Defendant: AUROBINDO PHARMA U.S.A., INC. and AUROBINDO PHARMA LIMITED
Plaintiff: PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AUROBINDO PHARMA LTD. et al
as 2:2020cv14833
Plaintiff: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. and NORTON (WATERFORD) LTD.
Defendant: AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD. and AUROLIFE PHARMA LLC
Cause Of Action: 15 U.S.C. § 1126
MERCK SHARP & DOHME CORP. v. AUROBINDO PHARMA USA INC. et al
as 3:2020cv10444
Defendant: AUROBINDO PHARMA USA INC., AUROBINDO PHARMA LTD. and AUROMEDICS PHARMA LLC
Plaintiff: MERCK SHARP & DOHME CORP.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC.
as 1:2020cv03102
Plaintiff: JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant: AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA INC.
as 3:2020cv03106
Plaintiff: JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant: AUROBINDO PHARMA USA INC.
Cause Of Action: 15 U.S.C. § 1126

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?